|
CDC42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69059999999277E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.602700E-04 |
| Normal-vs-Stage2 |
5.843900E-03 |
| Normal-vs-Stage3 |
2.13149999983564E-07 |
| Normal-vs-Stage4 |
1.23610000013485E-07 |
| Stage1-vs-Stage2 |
6.154200E-01 |
| Stage1-vs-Stage3 |
1.216900E-03 |
| Stage1-vs-Stage4 |
1.939890E-03 |
| Stage2-vs-Stage3 |
1.101550E-01 |
| Stage2-vs-Stage4 |
8.966100E-02 |
| Stage3-vs-Stage4 |
8.920800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56951999999988E-05 |
| Normal-vs-AfricanAmerican |
1.36669999983852E-07 |
| Normal-vs-Asian |
6.264000E-01 |
| Caucasian-vs-AfricanAmerican |
2.010400E-02 |
| Caucasian-vs-Asian |
4.275200E-01 |
| AfricanAmerican-vs-Asian |
2.954000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01290000007215E-07 |
| Normal-vs-Female |
5.046000E-04 |
| Male-vs-Female |
5.535900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.937770E-03 |
| Normal-vs-Age(41-60Yrs) |
1.818930E-04 |
| Normal-vs-Age(61-80Yrs) |
1.05900000002546E-06 |
| Normal-vs-Age(81-100Yrs) |
6.961100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.938200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.347400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.425800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.652000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.336400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.510000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.063800E-01 |
| Normal-vs-Grade 2 |
2.094000E-02 |
| Normal-vs-Grade 3 |
1.43479994552109E-09 |
| Normal-vs-Grade 4 |
5.58699997377232E-09 |
| Grade 1-vs-Grade 2 |
6.319000E-01 |
| Grade 1-vs-Grade 3 |
1.929980E-02 |
| Grade 1-vs-Grade 4 |
6.595200E-03 |
| Grade 2-vs-Grade 3 |
6.73249999971759E-07 |
| Grade 2-vs-Grade 4 |
2.38080000003471E-06 |
| Grade 3-vs-Grade 4 |
1.903990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.874200E-02 |
| Normal-vs-ccB subtype |
1.9559999997476E-07 |
| ccA subtype-vs-ccB subtype |
4.5846999996435E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.41960000000919E-05 |
| Normal-vs-N1 |
6.588800E-04 |
| N0-vs-N1 |
1.514240E-01 |
|
|
